X4 Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.26-$1.60 |
Market Cap | $114.2M |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $563,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $3M |
Diluted EPS | -$0.08 |
News
See moreYahoo Finance • last year
X4 Pharmaceuticals to Participate in Upcoming November Investor Conferences
Yahoo Finance • last year
X4 Pharmaceuticals Reports Third-Quarter 2023 Financial Results and Provides Corporate Updates
Yahoo Finance • last year
X4 Pharmaceuticals to Report Third-Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 9, 2023
Yahoo Finance • last year
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
About
CEO | Dr. Paula Ragan Ph.D. |
CFO | Mr. Adam S. Mostafa |
Address | 61 North Beacon Street, Boston, MA, United States, 02134 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 127 |
